Solicitation: FDA-RFI-1225598
The purpose of this RFI is to broaden FDA’s understanding of the market’s capability, either as solutions requiring potential development of a technology or existing commercially-available applications, to provide a Decision Support System (DSS) utilizing big data.
FDA receives large quantities of product and product-associated information and, upon receipt, a best course of action needs to be decided to protect public health. Legacy systems handling these data are generally siloed and limited, with the creation of interfaces or expansions time-consuming. Given advancing technologies, it is sought to transition to more flexible decision support systems capable of handling big data while still supporting the general operational processes in place.
A decision support system is needed that has the following capabilities:
- Inputs and warehouses structured and unstructured big data streams from both private and public data sources
Includes decision support features:
- application development and data sharing via application programming interfaces (API)
- data analysis
- forecasting
- decision tree analysis
- performance metrics
- rules-based workflow
